The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.
Application process for the Albus Awards 2022 is closed.
Candidates selected to submit a full proposal will be contacted on June 15th.
Applications for the next edition will be accepted between November 1, 2022 and April 30, 2023.
To see the 2021 ALBUS Award winners please click here.